Zhejiang Jolly Pharmaceutical Co., Ltd

The company was founded in January 2000 and is a national high-tech modern pharmaceutical enterprise integrating scientific research, production and sales. On February 22, 2011, the company successfully landed on the GEM. The company's main business is research and development, production and sales of pharmaceuticals. The company's products include Wuling series (Wuling capsules, Lingze tablets, Linglian granules), Bering series (Bering tablets, Bering capsules), traditional Chinese medicine tablets and traditional Chinese medicine formula granules, polycarbonate non-calcium tablets, etc. Corporate honors: In February 2024, it was rated as the first batch of “Zhejiang Traditional Chinese Medicine” industry brands, won the “Xipu Gold Award”, won the “National Civilized Unit”, “National Green Factory”, “Zhejiang Famous Trade Name”, “Zhejiang Provincial Credit Management Demonstration Enterprise”, “Zhejiang Traditional Chinese Medicine Culture Promotion and Education Base”, “2022 China's Top 100 Traditional Chinese Medicine Enterprises”, “China's Pharmaceutical Industry's Most Valuable Investment Enterprise in 2023", “China's Chinese Medicine Excellent Brand Enterprise in 2023", “China's Chinese Medicine Excellent Brand Enterprise in 2023",” Titles and honors include the top 50 growth companies in China's pharmaceutical industry in 2023-2022, “2023 Top 50 Comprehensive Competitiveness of Proprietary Chinese Medicines”, and “2023 Most Socially Responsible (ESG) Listed Company”.